Oncolytics Biotech (ONCY) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T18:58:05.706Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:58:05.706Z.

Quote observation: 2026-10-06T18:55:07.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.6001
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.26972318

FMP input reference: d71c6897c98d436948f76d79272a6a7ae3c560285f8867db41996dc6a6301e16

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

ONCY PE Ratio Metrics

PE RATIO

N/A

ONCY Competitors' PE Ratio

ONCY

Oncolytics Biotech Inc.

Current

Market Cap

$60.23M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XLO

Xilio Therapeutics, Inc.

vs ONCY

Market Cap

$60.03M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACET

Adicet Bio, Inc.

vs ONCY

Market Cap

$59.50M

PE Ratio

N/A

TTM Avg

110.41

3Y Avg

110.41

5Y Avg

110.41

KLRS

Kalaris Therapeutics Inc

vs ONCY

Market Cap

$61.01M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs ONCY

Market Cap

$59.40M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GUTS

Fractyl Health, Inc.

vs ONCY

Market Cap

$61.34M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTB

Connect Biopharma Holdings Limited

vs ONCY

Market Cap

$58.69M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BOLD

Boundless Bio, Inc.

vs ONCY

Market Cap

$58.66M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INKT

MiNK Therapeutics, Inc.

vs ONCY

Market Cap

$58.59M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HRTX

Heron Therapeutics, Inc.

vs ONCY

Market Cap

$62.71M

PE Ratio

N/A

TTM Avg

2.96

3Y Avg

2.96

5Y Avg

2.96

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Oncolytics Biotech Inc. (ONCY)	$60.23M	N/A	N/A	N/A	N/A
Xilio Therapeutics, Inc. (XLO)vs ›	$60.03M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$59.50M	N/A	110.41	110.41	110.41
Kalaris Therapeutics Inc (KLRS)vs ›	$61.01M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$59.40M	N/A	N/A	N/A	N/A
Fractyl Health, Inc. (GUTS)vs ›	$61.34M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$58.69M	N/A	N/A	N/A	N/A
Boundless Bio, Inc. (BOLD)vs ›	$58.66M	N/A	N/A	N/A	N/A
MiNK Therapeutics, Inc. (INKT)vs ›	$58.59M	N/A	N/A	N/A	N/A
Heron Therapeutics, Inc. (HRTX)vs ›	$62.71M	N/A	2.96	2.96	2.96

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

ONCY PE Ratio Metrics

ONCY Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics